On Being the Right Size: The Impact of Population Size and Stochastic Effects on the Evolution of Drug Resistance in Hospitals and the Community

The evolution of drug resistant bacteria is a severe public health problem, both in hospitals and in the community. Currently, some countries aim at concentrating highly specialized services in large hospitals in order to improve patient outcomes. Emergent resistant strains often originate in health care facilities, but it is unknown to what extent hospital size affects resistance evolution and the resulting spillover of hospital-associated pathogens to the community. We used two published datasets from the US and Ireland to investigate the effects of hospital size and controlled for several confounders such as antimicrobial usage, sampling frequency, mortality, disinfection and length of stay. The proportion of patients acquiring both sensitive and resistant infections in a hospital strongly correlated with hospital size. Moreover, we observe the same pattern for both the percentage of resistant infections and the increase of hospital-acquired infections over time. One interpretation of this pattern is that chance effects in small hospitals impede the spread of drug-resistance. To investigate to what extent the size distribution of hospitals can directly affect the prevalence of antibiotic resistance, we use a stochastic epidemiological model describing the spread of drug resistance in a hospital setting as well as the interaction between one or several hospitals and the community. We show that the level of drug resistance typically increases with population size: In small hospitals chance effects cause large fluctuations in pathogen population size or even extinctions, both of which impede the acquisition and spread of drug resistance. Finally, we show that indirect transmission via environmental reservoirs can reduce the effect of hospital size because the slow turnover in the environment can prevent extinction of resistant strains. This implies that reducing environmental transmission is especially important in small hospitals, because such a reduction not only reduces overall transmission but might also facilitate the extinction of resistant strains. Overall, our study shows that the distribution of hospital sizes is a crucial factor for the spread of drug resistance.

[1]  Pia Abel zur Wiesch,et al.  Population biological principles of drug-resistance evolution in infectious diseases. , 2011, The Lancet. Infectious diseases.

[2]  J. Townsend,et al.  Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures , 2011, The Journal of antimicrobial chemotherapy.

[3]  L. Hsu,et al.  Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.

[4]  F. DeLeo,et al.  Community-associated meticillin-resistant Staphylococcus aureus , 2010, The Lancet.

[5]  P. Böelle,et al.  Antibiotic Dose Impact on Resistance Selection in the Community: a Mathematical Model of β-Lactams and Streptococcus pneumoniae Dynamics , 2010, Antimicrobial Agents and Chemotherapy.

[6]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[7]  Andrew R. Francis,et al.  The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.

[8]  France Mentré,et al.  Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. , 2009, Archives of internal medicine.

[9]  A. Sousa,et al.  Positive Epistasis Drives the Acquisition of Multidrug Resistance , 2009, PLoS genetics.

[10]  R. Neumar,et al.  A national analysis of the relationship between hospital factors and post-cardiac arrest mortality , 2009, Intensive Care Medicine.

[11]  Bengt Åhgren Is it better to be big? The reconfiguration of 21st century hospitals: responses to a hospital merger in Sweden. , 2008, Health policy.

[12]  J. Chastre Evolving problems with resistant pathogens. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  F. Daschner,et al.  Antibiotic use in two cohorts of German intensive care units. , 2006, The Journal of hospital infection.

[14]  P. Nordmann,et al.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  J. Vaqué,et al.  Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). , 2006, The Journal of hospital infection.

[16]  A. Troelstra,et al.  Extensive Hospital-Wide Spread of a Multidrug-Resistant Enterobacter cloacae Clone, with Late Detection Due to a Variable Antibiogram and Frequent Patient Transfer , 2006, Journal of Clinical Microbiology.

[17]  A. Troelstra,et al.  Antibiotic rotation and development of gram-negative antibiotic resistance. , 2005, American journal of respiratory and critical care medicine.

[18]  David L. Smith,et al.  Strategic interactions in multi-institutional epidemics of antibiotic resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[20]  D. Zoutman,et al.  The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. , 2005, American journal of infection control.

[21]  Carl T. Bergstrom,et al.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Ronald N. Jones,et al.  Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Quinn,et al.  Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. , 2003, JAMA.

[24]  D. Gillespie Approximate accelerated stochastic simulation of chemically reacting systems , 2001 .

[25]  O. Cars,et al.  Variation in antibiotic use in the European Union , 2001, The Lancet.

[26]  D. Mckillop,et al.  Investigating productivity change and hospital size: a nonparametric frontier approach , 2000 .

[27]  Alice N. Neely,et al.  Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic , 2000, Journal of Clinical Microbiology.

[28]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D Draper,et al.  Hospital characteristics and quality of care. , 1992, JAMA.

[30]  D. Hartl,et al.  Principles of population genetics , 1981 .

[31]  D. Gillespie A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[32]  R. Punnett,et al.  The Genetical Theory of Natural Selection , 1930, Nature.